Brokers' take

Venture Corporation > Buy DBS Group Research, Oct 6 Oct 6 close: S$18.45 Target price: S$21.00

IN THE recent quarter, Venture announced a historical-high quarterly performance. The company has demonstrated consistent revenue growth (on a year-on-year basis) for the last 15 quarters. With earnings growth trajectory gaining momentum over the last five quarters due to its exposure in attractive end-markets such as genome sequencing and networking and communications, we believe that the strong growth momentum is likely to continue amidst its CEO's share purchases in the open market since July. We maintain our BUY call with a revised target price of S$21.00 as we believe the earnings growth prospects and potential dividend upside are attractive attributes.

We currently have the highest target price on the street. We remain positive on Venture's growth trajectory and believe the market has yet to fully price in the company's growth potential given its unique offerings, superior technology know-how and hard-to-replicate ecosystems.